Can a smartphone program and glucose monitor reduce heart risks after gestational diabetes?
NCT ID NCT06648174
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests whether a lifestyle program delivered through a mobile app, combined with a continuous glucose monitor (Abbott FreeStyle Libre 2), can improve blood sugar control and reduce cardiometabolic risk in 120 pregnant women diagnosed with gestational diabetes. Participants wear the glucose monitor during pregnancy and receive personalized feedback. The goal is to see if this approach leads to better health outcomes for both mother and baby.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Continuous glucose monitor (Abbott FreeStyle Libre 2) and a lifestyle intervention based on the health belief model, delivered via mobile health
What this could lead to
If successful, this approach could help women with gestational diabetes better control their blood sugar and reduce long-term heart and metabolic risks.
What could go wrong
This is a small, early-stage study (120 participants) testing a behavioral intervention, so results may not apply broadly. The lifestyle program requires active participation, and the glucose monitor may cause skin irritation in some users.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Taiwan University Hospital Hsin-Chu Branch BioMedical Park Hospital
RECRUITINGHsinchu, 302058, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••